Results 11 to 20 of about 37,897 (253)

QUETIAPINE

Journal of Prescribing Practice, 2022
In this column, Sharon Rees aims to refresh knowledge and interest in some of the commonly used drugs in a series of tweets. This month she is talking about #quetiapine
  +6 more sources

Quetiapine Extended-Release and Peripheral Edema: A Case Report and Literature Review. [PDF]

Case Rep Psychiatry
Chatterjee SS, Mukherjee S, Das S, Kayal M, Mondal S.   +4 more
europepmc   +3 more sources

Efficacy and Tolerance of Antipsychotics Used for the Treatment of Patients Newly Diagnosed with Schizophrenia: A Systematic Review and Meta-Analysis

Pharmacy, 2023
This systematic review compared the efficacy and tolerance of oral antipsychotics (APDs) used in the treatment of schizophrenia following the PRISMA-P© statement (n = 21).
Zina Sherzad Qadir, Patrick Anthony Ball, Hana Morrissey   +2 more
doaj   +1 more source

Low doses of mirtazapine or quetiapine for transient insomnia: A randomised, double-blind, cross-over, placebo-controlled trial

Journal of Psychopharmacology, 2017
Julie Karsten, Loes A. Hagenauw, Jeanine Kamphuis, Marike Lancel   +3 more
openalex   +3 more sources

Quetiapine

Reactions Weekly, 2006
europepmc   +3 more sources

Cardiac adverse events associated with quetiapine: Disproportionality analysis of FDA adverse event reporting system

CNS Neuroscience & Therapeutics, 2023
Objective Quetiapine, an atypical second‐generation antipsychotic drug, is approved for treatment of schizophrenia, bipolar disorder, and depression. Due to the limitations of clinical trials, the association between quetiapine and rare cardiac adverse ...
Yamin Shu, Yiling Ding, Lulu Liu, Qilin Zhang   +3 more
semanticscholar   +1 more source

Use of low‐dose quetiapine increases the risk of major adverse cardiovascular events: results from a nationwide active comparator‐controlled cohort study

World Psychiatry, 2022
At standard doses used for schizophrenia or bipolar disorder, quetiapine has been associated with weight gain and increased levels of triglycerides, total cholesterol and low‐density lipoprotein (LDL) cholesterol, which are risk factors for ...
M. Højlund, K. Andersen, M. Ernst, C. Correll, J. Hallas   +4 more
semanticscholar   +1 more source

Quetiapine for primary insomnia: Consider the risks

Cleveland Clinic journal of medicine, 2021
The second-generation antipsychotic drug quetiapine (Seroquel) is increasingly being used off-label for treating insomnia in the general population, possibly to avoid standard medications with known addictive qualities and adverse side effects.
V. Modesto-Lowe, Agata Harabasz, Sophia A. Walker   +2 more
semanticscholar   +1 more source

Who prescribes quetiapine in Denmark?

British Journal of Clinical Pharmacology, 2022
The second‐generation antipsychotic quetiapine is commonly used off‐label for its anxiolytic and hypnotic properties. However, quetiapine is associated with problematic side‐effects.
M. Højlund, L. Rasmussen, M. Olesen, T. Munk-Olsen, A. Pottegård   +4 more
semanticscholar   +1 more source

Quetiapine-Induced Place Preference in Mice: Possible Dopaminergic Pathway

Pharmaceuticals, 2021
Quetiapine, an atypical antipsychotic, is effective in the management of schizophrenia, depression, and anxiety. Although quetiapine overdosage and misuse have been reported, its abuse potential has not been investigated in animals.
Yusuf S. Althobaiti
doaj   +1 more source